115 related articles for article (PubMed ID: 36728750)
21. Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification.
Yamashita K; Kohashi K; Yamada Y; Ishii T; Nishida Y; Urakawa H; Ito I; Takahashi M; Inoue T; Ito M; Ohara Y; Oda Y; Toyokuni S
Histopathology; 2018 Apr; 72(5):729-738. PubMed ID: 29076540
[TBL] [Abstract][Full Text] [Related]
22. Dedifferentiated liposarcoma of the musculoskeletal system: expanded MR imaging spectrum from predominant fatty mass to non-fatty mass.
Yun JS; Chung HW; Song JS; Lee SH; Lee MH; Shin MJ
Acta Radiol; 2019 Nov; 60(11):1474-1481. PubMed ID: 30907094
[No Abstract] [Full Text] [Related]
23. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
Song MJ; Cho KJ; Lee JS; Song JS
Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
[TBL] [Abstract][Full Text] [Related]
24. Primary Extremity Liposarcoma: MRI Features, Histopathology, and Clinical Outcomes.
Wortman JR; Tirumani SH; Jagannathan JP; Tirumani H; Shinagare AB; Hornick JL; Ramaiya NH
J Comput Assist Tomogr; 2016; 40(5):791-8. PubMed ID: 27224232
[TBL] [Abstract][Full Text] [Related]
25. Application of adipocyte-related antibodies in undifferentiated sarcomas to identify dedifferentiated liposarcomas based on histological and clinical analysis.
Im S; Park HS; Cho U; Yoo C; Jung JH; Choi HJ; Yoo J
Int J Clin Exp Pathol; 2018; 11(4):2246-2255. PubMed ID: 31938337
[TBL] [Abstract][Full Text] [Related]
26. Degree of
Bill KLJ; Seligson ND; Hays JL; Awasthi A; Demoret B; Stets CW; Duggan MC; Bupathi M; Brock GN; Millis SZ; Shakya R; Timmers CD; Wakely PE; Pollock RE; Chen JL
Oncologist; 2019 Jul; 24(7):989-996. PubMed ID: 31019022
[TBL] [Abstract][Full Text] [Related]
27. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?
Bhosale P; Wang J; Varma D; Jensen C; Patnana M; Wei W; Chauhan A; Feig B; Patel S; Somaiah N; Sagebiel T
J Comput Assist Tomogr; 2016; 40(6):872-879. PubMed ID: 27454788
[TBL] [Abstract][Full Text] [Related]
28.
Casadei L; Calore F; Braggio DA; Zewdu A; Deshmukh AA; Fadda P; Lopez G; Wabitsch M; Song C; Leight JL; Grignol VP; Lev D; Croce CM; Pollock RE
Cancer Res; 2019 Oct; 79(19):4911-4922. PubMed ID: 31387924
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of dedifferentiated liposarcoma in the extremities: A retrospective case series of 7 patients.
Kito M; Yoshimura Y; Isobe K; Aoki K; Suzuki S; Tanaka A; Okamoto M; Sano K; Kato H
J Orthop Sci; 2016 Sep; 21(5):673-7. PubMed ID: 27317086
[TBL] [Abstract][Full Text] [Related]
30. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
31. Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.
Makise N; Yoshida A; Komiyama M; Nakatani F; Yonemori K; Kawai A; Fukayama M; Hiraoka N
Am J Surg Pathol; 2017 Nov; 41(11):1523-1531. PubMed ID: 28719466
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
33. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
[TBL] [Abstract][Full Text] [Related]
35. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours.
Liau JY; Lee JC; Wu CT; Kuo KT; Huang HY; Liang CW
Histopathology; 2013 Apr; 62(5):702-10. PubMed ID: 23425231
[TBL] [Abstract][Full Text] [Related]
36. Dedifferentiated liposarcoma of the extremities: imaging findings in four patients.
Kransdorf MJ; Meis JM; Jelinek JS
AJR Am J Roentgenol; 1993 Jul; 161(1):127-30. PubMed ID: 8517290
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Iwata S; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
[TBL] [Abstract][Full Text] [Related]
38. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.
Lu J; Wood D; Ingley E; Koks S; Wong D
Mol Biol Rep; 2021 Apr; 48(4):3637-3647. PubMed ID: 33893924
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
[No Abstract] [Full Text] [Related]
40. Retroperitoneal dedifferentiated liposarcoma with huge cystic degeneration: A case report.
Uchihashi K; Matsuyama A; Shiba E; Kimura Y; Ogata T; Yabuki K; Harada H; Kubo C; Tsuda Y; Jotatsu M; Hisaoka M
Pathol Int; 2017 May; 67(5):264-268. PubMed ID: 28337832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]